AlphaCrest Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

AlphaCrest Capital Management’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,253	Closed	-$348K	–	1220
2022 Q3	$348K	Sell	1,253 -213	-15%	-$54.2K	0.02%	1106
2022 Q2	$280K	Sell	1,466 -1,729	-54%	-$305K	0.01%	1137
2022 Q1	$663K	Sell	3,195 -85	-3%	-$14K	0.04%	756
2021 Q4	$585K	Sell	3,280 -855	-21%	-$169K	0.02%	1043
2021 Q3	$851K	Buy	+4,135	New	+$812K	0.04%	678
2021 Q1	–	Sell	-5,500	Closed	-$570K	–	1338
2020 Q4	$570K	Buy	5,500 +2,200	+67%	+$191K	0.05%	580
2020 Q3	$250K	Buy	+3,300	New	+$187K	0.03%	955

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCrest Capital Management's SWAV Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2022, closing a stake of 1,253 shares — an estimated $348K sold.

AlphaCrest Capital Management first reported a position in SWAV in Q3 2020 and held it in 7 quarters. The position peaked at $851K in Q3 2021. 415 funds tracked by Wall St. Rank hold SWAV as of Q4 2022.

AlphaCrest Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 1,253 Shockwave Medical, Inc. Common Stock shares in Q4 2022, an estimated $348K.
AlphaCrest Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
AlphaCrest Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $851K in Q3 2021.
415 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.